Press Center: Legal updates

From 1 September 2026, new rules for calculating remuneration for employees who are the authors of employee inventions, utility models and industrial designs will come into force. The document fundamentally changes the approach to such payments.

The Russian Ministry of Health’s draft law “On Amending Certain Legislative Acts of the Russian Federation…” (“the Draft Law”), concerning changes to the control of the circulation of medicinal products has been published on the federal portal for draft regulatory acts.

On June 1, 2026, the decision of the Bank of Russia Working Group dated June 1, 2026  No. PRG-43-11/1199 (hereinafter – “Decision”) and Presidential Decree No. 377 dated June 1, 2026 “On Amending Presidential Decree No. 95 of March 5, 2022 ‘On the Temporary Procedure for Fulfilling Obligations to Certain Foreign Creditors’” (hereinafter – “Decree No. 377”) were published, introducing changes to the current counter-sanctions regulation.

Since the beginning of 2025, Russian courts have issued several landmark rulings in the field of personal data processing. These cases affect the interests of banks, marketplaces, solid waste management operators, employers, and online platforms. Some positions confirm long-standing approaches (withdrawal of consent does not terminate processing where a contract or legal obligation exists), while others establish new guidelines for businesses (processing of a beneficiary's data without consent, inadmissibility of contacting a previous employer without the candidate's permission).

Our review covers seven recent cases with conclusions that will help DPOs, legal teams, and information security departments minimize risks and establish compliant processes.

As part of the implementation of the Strategy for the Development of the Pharmaceutical Industry through 2030, approved by Decree of the Government of the Russian Federation No. 1495-r of 7 June 2023 (“Pharma Strategy 2030”), and discussions at the “Healthy Society” forum organized by the Roscongress Foundation with the support of the Ministry of Health (16–17 March 2026, Moscow) (“Forum”), key areas of state support for domestic drug developers and manufacturers were identified, including subsidies for clinical trials .

In addition to existing support programs, subsidies for clinical trials at all stages will help overcome the financing barrier for high-risk phases of medicines clinical trials and accelerate the market launch of medicines. The combination of current and planned measures will create the legal and economic foundation for strengthening the production and technological capacity of the domestic pharmaceutical industry and increasing its presence in international markets.

Below, we will examine planned initiatives and support measures for pharmaceutical manufacturers that have already been implemented.

On 29 April 2026, the Constitutional Court of the Russian Federation (the “CCRF”) has published its case law review for the first quarter of 2026, comprising 19 judgments and 6 rulings. The document systematizes decisions across administrative, labor, private and criminal law, establishing new standards for the protection of individuals and businesses.

On March 30, 2026, the State Duma received bill №. 1191453-8 (hereinafter "bill"), which is planned to amend the CPC norm on alternative jurisdiction. The subject of the legislative initiative was the Government of the Russian Federation.

On April 21, 2026, the State Duma adopted Bill No. 1077246-8 in its third reading, introducing amendments to the Code of Administrative Offenses of the Russian Federation (CAO RF). These innovations are aimed at expanding the rights of participants in administrative offense proceedings and unifying procedural legislation.

Active public discussions continue regarding the draft law “On the Foundations of State Regulation of Artificial Intelligence Technology Applications in the Russian Federation”, drafted by the Ministry of Digital Development of the Russian Federation. The document covers the development, implementation and use of artificial intelligence (hereinafter – “AI”), and establishes obligations for service owners, developers and users. Below is an overview of the key changes that will affect businesses.